Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

The risk of cancer development in systemic sclerosis: a meta-analysis.

Zhang JQ, Wan YN, Peng WJ, Yan JW, Li BZ, Mei B, Chen B, Yao H, Yang GJ, Tao JH, Wang J.

Cancer Epidemiol. 2013 Oct;37(5):523-7. doi: 10.1016/j.canep.2013.04.014. Epub 2013 May 29.

PMID:
23725641
2.

Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies.

Onishi A, Sugiyama D, Kumagai S, Morinobu A.

Arthritis Rheum. 2013 Jul;65(7):1913-21. doi: 10.1002/art.37969. Review.

3.

Cancer risk among patients with systemic sclerosis: a nationwide population study in Taiwan.

Kuo CF, Luo SF, Yu KH, Chou IJ, Tseng WY, Chang HC, Fang YF, Chiou MJ, See LC.

Scand J Rheumatol. 2012 Feb;41(1):44-9. doi: 10.3109/03009742.2011.618145. Epub 2011 Dec 11.

PMID:
22150162
4.

Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies.

Bonifazi M, Tramacere I, Pomponio G, Gabrielli B, Avvedimento EV, La Vecchia C, Negri E, Gabrielli A.

Rheumatology (Oxford). 2013 Jan;52(1):143-54. doi: 10.1093/rheumatology/kes303. Epub 2012 Nov 22. Review.

PMID:
23175568
5.

Malignancies associated with systemic sclerosis.

Szekanecz É, Szamosi S, Horváth Á, Németh Á, Juhász B, Szántó J, Szücs G, Szekanecz Z.

Autoimmun Rev. 2012 Oct;11(12):852-5. doi: 10.1016/j.autrev.2012.02.021. Epub 2012 Mar 5. Review.

PMID:
22410174
6.

The risk of lymphoma development in autoimmune diseases: a meta-analysis.

Zintzaras E, Voulgarelis M, Moutsopoulos HM.

Arch Intern Med. 2005 Nov 14;165(20):2337-44. Review.

PMID:
16287762
7.

Incidence of cancer among patients with systemic sclerosis in Korea: results from a single centre.

Kang KY, Yim HW, Kim IJ, Yoon JU, Ju JH, Kim HY, Park SH.

Scand J Rheumatol. 2009;38(4):299-303. doi: 10.1080/03009740802642062.

PMID:
19308805
8.

A cohort study of cancer incidence in systemic sclerosis.

Derk CT, Rasheed M, Artlett CM, Jimenez SA.

J Rheumatol. 2006 Jun;33(6):1113-6. Epub 2006 Mar 15.

PMID:
16622904
9.

Incidence and the risk factor of malignancy in Japanese patients with systemic sclerosis.

Hashimoto A, Arinuma Y, Nagai T, Tanaka S, Matsui T, Tohma S, Endo H, Hirohata S.

Intern Med. 2012;51(13):1683-8. Epub 2012 Jul 1.

10.

Malignancy in systemic lupus erythematosus.

Abu-Shakra M, Gladman DD, Urowitz MB.

Arthritis Rheum. 1996 Jun;39(6):1050-4.

PMID:
8651970
11.

Incidence of cancer among patients with systemic sclerosis.

Rosenthal AK, McLaughlin JK, Gridley G, Nyrén O.

Cancer. 1995 Sep 1;76(5):910-4.

12.

Cancer in systemic sclerosis.

Abu-Shakra M, Guillemin F, Lee P.

Arthritis Rheum. 1993 Apr;36(4):460-4.

PMID:
8457221
13.

Incidence of lung cancer in patients with systemic sclerosis treated with extracorporeal photopheresis.

Topuzoglu S, Knobler R, Movadat O, Petkov V, Foedinger D, Just U, Pehamberger H, Jantschitsch C.

Photodermatol Photoimmunol Photomed. 2015 Jul;31(4):175-83. doi: 10.1111/phpp.12155. Epub 2015 Jan 15.

PMID:
25495608
14.

A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis.

Smitten AL, Simon TA, Hochberg MC, Suissa S.

Arthritis Res Ther. 2008;10(2):R45. doi: 10.1186/ar2404. Epub 2008 Apr 23.

15.

Risk of Hodgkin's disease and other cancers after infectious mononucleosis.

Hjalgrim H, Askling J, Sørensen P, Madsen M, Rosdahl N, Storm HH, Hamilton-Dutoit S, Eriksen LS, Frisch M, Ekbom A, Melbye M.

J Natl Cancer Inst. 2000 Sep 20;92(18):1522-8.

PMID:
10995808
16.

Cancer incidence in the rural community of Tecumseh, Michigan: a pattern of increased lymphopoietic neoplasms.

Waterhouse D, Carman WJ, Schottenfeld D, Gridley G, McLean S.

Cancer. 1996 Feb 15;77(4):763-70.

17.

Anticentromere antibody as a risk factor for cancer in patients with systemic sclerosis.

Higuchi M, Horiuchi T, Ishibashi N, Yoshizawa S, Niho Y, Nagasawa K.

Clin Rheumatol. 2000;19(2):123-6.

PMID:
10791623
18.

High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.

Dreyer L, Faurschou M, Mogensen M, Jacobsen S.

Arthritis Rheum. 2011 Oct;63(10):3032-7. doi: 10.1002/art.30483.

19.

Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.

Muangchan C, Harding S, Khimdas S, Bonner A; Canadian Scleroderma Research group, Baron M, Pope J.

Arthritis Care Res (Hoboken). 2012 Sep;64(9):1405-14. doi: 10.1002/acr.21716.

20.

Incidence of Cancer in ANCA-Associated Vasculitis: A Meta-Analysis of Observational Studies.

Shang W, Ning Y, Xu X, Li M, Guo S, Han M, Zeng R, Ge S, Xu G.

PLoS One. 2015 May 14;10(5):e0126016. doi: 10.1371/journal.pone.0126016. eCollection 2015.

Supplemental Content

Support Center